Evidence map›Paper›PMID 30813231›Full record

ArticleInternational journal of molecular sciences2019

Integrated Multi-Assay Culture Model for Stem Cell Chondrogenic Differentiation.

Amy Prosser, Colin Scotchford, George Roberts, David Grant, Virginie Sottile

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in bioengineering and biotechnology · 2022
    Article
  18. Ex Vivo Systems to Study Chondrogenic Differentiation and Cartilage Integration.Journal of functional morphology and kinesiology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amy ProsserWolfson STEM Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK. amy.prosser@nottingham.ac.uk.
Colin ScotchfordAdvanced Biomaterials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK. colin.scotchford@nottingham.ac.uk.
George RobertsAdvanced Biomaterials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK. george.roberts@nottingham.ac.uk.
David GrantAdvanced Biomaterials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, UK. david.grant@nottingham.ac.uk.
Virginie SottileWolfson STEM Centre, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK. virginie.sottile@nottingham.ac.uk.
University of Nottingham · GB

Funding

ACTIVE SPECIFIC IMMUNOTHERAPY IN MAN: A MURINE MODELR01CA029592 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KAHAN, BARRY D · 1985 to 1987
–
ACTIVE SPECIFIC IMMUNOTHERAPY IN MAN: A MURINE MODELR37CA029592 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KAHAN, BARRY D · 1988 to 1992
–
Engineering and Physical Sciences Research Council grant number EP/K029592/1Seventh Framework Programme (FP7/2007- 2013) under grant agreement no. 263363
6 · The paper itself

Abstract

Recent osteochondral repair strategies highlight the promise of mesenchymal progenitors, an accessible stem cell source with osteogenic and chondrogenic potential, used in conjunction with biomaterials for tissue engineering. For this, regenerative medicine approaches require robust models to ensure selected cell populations can generate the desired cell type in a reproducible and measurable manner. Techniques for in vitro chondrogenic differentiation are well-established but largely qualitative, relying on sample staining and imaging. To facilitate the in vitro screening of pro-chondrogenic treatments, a 3D micropellet culture combined with three quantitative GAG assays has been developed, with a fourth parallel assay measuring sample content to enable normalisation. The effect of transforming growth factor beta (TGF-β) used to validate this culture format produced a measurable increase in proteoglycan production in the parallel assays, in both 2D and 3D culture configurations. When compared to traditional micropellets, the monolayer format appeared less able to detect changes in cell differentiation, however in-well 3D cultures displayed a significant differential response. Effects on collagen 2 expression confirmed these observations. Based on these results, a microplate format was optimised for 3D culture, in a high-throughput in-well configuration. This model showed improved sensitivity and confirmed the 3D micropellet in-well quantitative assays as an effective differentiation format compatible with streamlined, high-throughput chondrogenic screens.

Indexed as

Cell DifferentiationChondrogenesisModels, BiologicalBiological AssayCells, CulturedCollagen Type IIGenes, ReporterGlucoseHumansStem CellsCollagen Type IIGlucose3D culturechondrogenesismultimodal analysisquantitative assaystem cell differentiation

Identifiers

PMID30813231
PMCPMC6413173
OpenAlexW2916634949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.